Liana K Billings1, Kathleen A Jablonski, Rachel J Ackerman, Andrew Taylor, Rebecca R Fanelli, Jarred B McAteer, Candace Guiducci, Linda M Delahanty, Dana Dabelea, Steven E Kahn, Paul W Franks, Robert L Hanson, Nisa M Maruthur, Alan R Shuldiner, Elizabeth J Mayer-Davis, William C Knowler, Jose C Florez. 1. Center for Human Genetic Research (L.K.B., R.J.A., A.T., R.R.F., J.B.M., J.C.F.) and Diabetes Research Center (Diabetes Unit) (L.K.B., L.M.D., J.C.F.), Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114; Department of Medicine (L.K.B., L.M.D., J.C.F.), Harvard Medical School, and Department of Nutrition (P.W.F.), Harvard School of Public Health, Boston, Massachusetts 02115; Department of Medicine (L.K.B.), NorthShore University HealthSystem, Evanston, Illinois 60201; University of Chicago (L.K.B.), Pritzker School of Medicine, Chicago, Illinois 60637; The Biostatistics Center (K.A.J.), George Washington University, Rockville, Maryland 20852; Program in Medical and Population Genetics (A.T., J.B.M., C.G., J.C.F.), Broad Institute, Cambridge, Massachusetts 02142; Department of Epidemiology (D.D.), Colorado School of Public Health, University of Colorado, Denver, Colorado 80045; Division of Metabolism, Endocrinology, and Nutrition (S.E.K.), VA Puget Sound Health Care System and University of Washington, Seattle, Washington 98108; Department of Clinical Sciences (P.W.F.), Genetic and Molecular Epidemiology Unit, Lund University, SE-200 41 Malmö, Sweden; Diabetes Epidemiology and Clinical Research Section (R.L.H., W.C.K.), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona 85014; Department of Medicine (N.M.M.), Division of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205; Department of Medicine (A.R.S.), Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland 21201; and Department of Nutrition (E.J.M.-D.), University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina 27599.
Abstract
CONTEXT/ OBJECTIVE: The variant rs13266634 in SLC30A8, encoding a β-cell-specific zinc transporter, is associated with type 2 diabetes. We aimed to identify other variants in SLC30A8 that increase diabetes risk and impair β-cell function, and test whether zinc intake modifies this risk. DESIGN/OUTCOME: We sequenced exons in SLC30A8 in 380 Diabetes Prevention Program (DPP) participants and identified 44 novel variants, which were genotyped in 3445 DPP participants and tested for association with diabetes incidence and measures of insulin secretion and processing. We examined individual common variants and used gene burden tests to test 39 rare variants in aggregate. RESULTS: We detected a near-nominal association between a rare-variant genotype risk score and diabetes risk. Five common variants were associated with the oral disposition index. Various methods aggregating rare variants demonstrated associations with changes in oral disposition index and insulinogenic index during year 1 of follow-up. We did not find a clear interaction of zinc intake with genotype on diabetes incidence. CONCLUSIONS: Individual common and an aggregate of rare genetic variation in SLC30A8 are associated with measures of β-cell function in the DPP. Exploring rare variation may complement ongoing efforts to uncover the genetic influences that underlie complex diseases.
CONTEXT/ OBJECTIVE: The variant rs13266634 in SLC30A8, encoding a β-cell-specific zinc transporter, is associated with type 2 diabetes. We aimed to identify other variants in SLC30A8 that increase diabetes risk and impair β-cell function, and test whether zinc intake modifies this risk. DESIGN/OUTCOME: We sequenced exons in SLC30A8 in 380 Diabetes Prevention Program (DPP) participants and identified 44 novel variants, which were genotyped in 3445 DPPparticipants and tested for association with diabetes incidence and measures of insulin secretion and processing. We examined individual common variants and used gene burden tests to test 39 rare variants in aggregate. RESULTS: We detected a near-nominal association between a rare-variant genotype risk score and diabetes risk. Five common variants were associated with the oral disposition index. Various methods aggregating rare variants demonstrated associations with changes in oral disposition index and insulinogenic index during year 1 of follow-up. We did not find a clear interaction of zinc intake with genotype on diabetes incidence. CONCLUSIONS: Individual common and an aggregate of rare genetic variation in SLC30A8 are associated with measures of β-cell function in the DPP. Exploring rare variation may complement ongoing efforts to uncover the genetic influences that underlie complex diseases.
Authors: A R Majithia; K A Jablonski; J B McAteer; K J Mather; R B Goldberg; S E Kahn; J C Florez Journal: Diabetologia Date: 2011-07-21 Impact factor: 10.122
Authors: Elizabeth J Mayer-Davis; Karen C Sparks; Katherine Hirst; Tina Costacou; Jennifer C Lovejoy; Judith G Regensteiner; Mary A Hoskin; Andrea M Kriska; George A Bray Journal: Ann Epidemiol Date: 2004-11 Impact factor: 3.797
Authors: K Kirchhoff; F Machicao; A Haupt; S A Schäfer; O Tschritter; H Staiger; N Stefan; H-U Häring; A Fritsche Journal: Diabetologia Date: 2008-02-09 Impact factor: 10.122
Authors: Allan F Moore; Kathleen A Jablonski; Jarred B McAteer; Richa Saxena; Toni I Pollin; Paul W Franks; Robert L Hanson; Alan R Shuldiner; William C Knowler; David Altshuler; Jose C Florez Journal: Diabetes Date: 2008-06-10 Impact factor: 9.461
Authors: K J Mather; C Kim; C A Christophi; V R Aroda; W C Knowler; S E Edelstein; J C Florez; F Labrie; S E Kahn; R B Goldberg; E Barrett-Connor Journal: J Clin Endocrinol Metab Date: 2015-07-22 Impact factor: 5.958
Authors: Karla Fabiana Brasil Gomes; Cintia Semzezem; Rodolfo Batista; Rosa Tsuneshiro Fukui; Aritania Sousa Santos; Márcia Regina Correia; Maria Rita Passos-Bueno; Maria Elizabeth Rossi da Silva Journal: Sci Rep Date: 2017-03-16 Impact factor: 4.379
Authors: Steven E Kahn; Yi-Chun Chen; Nathalie Esser; Austin J Taylor; Daniël H van Raalte; Sakeneh Zraika; C Bruce Verchere Journal: Endocr Rev Date: 2021-09-28 Impact factor: 25.261